AVIR PEER ANALYSIS

Atea Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

AVIRAtea Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

AVIRIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	AVIR	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.89	17.91
P/B	1.69	—	6.37	0.61●	3.51
EV/EBITDA	—	—	120.14	74.61●	14.82
P/S	—	31.61	3.24●	6.67	10.89

Financial Health
Metric	AVIR	MSB	TLX	RTALB	Ind. Median
Current Ratio	7.89●	—	1.43	1.21	5.90
Debt/Equity	0.3%●	—	112.3%	1.2%	10.9%
NetDebt/EBITDA	1.42	—	13.13	0.90●	1.15

Profitability
Metric	AVIR	MSB	TLX	RTALB	Ind. Median
Net Margin	—	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-52.6%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-48.0%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	—	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	AVIR	MSB	TLX	RTALB	Ind. Median
Rev. Growth	-100.0%	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	AVIR	ALT	PRLD	FENC	VNDA	FHTX	Ind. Median
P/E	—	—	—	—	—	—	17.91
P/B	1.69	1.38	6.73	10.10	1.32	-4.82●	3.51
EV/EBITDA	—	—	—	—	—	—	14.82
P/S	—	10,924.98	24.23	7.46	1.70●	13.06	10.89

Financial Health
Metric	AVIR	ALT	PRLD	FENC	VNDA	FHTX	Ind. Median
Current Ratio	7.89	29.56●	2.03	6.98	2.16	2.92	5.90
Debt/Equity	0.3%	12.6%	29.4%	—	4.7%	-55.0%●	10.9%
NetDebt/EBITDA	1.42	3.35	0.84●	—	1.39	1.97	1.15

Profitability
Metric	AVIR	ALT	PRLD	FENC	VNDA	FHTX	Ind. Median
Net Margin	—	-253,002.8%	-465.3%	-16.4%●	-110.0%	-266.9%	-125.7%
ROE	-52.6%	-42.7%●	-95.2%	-52.7%	-60.5%	—	-47.5%
ROA	-48.0%	-37.0%	-59.6%	-14.2%●	-45.0%	-31.3%	-35.8%
EBITDA Margin	—	-245,200.0%	-455.3%	-13.1%●	-62.6%	-257.0%	-105.8%

Growth + Dividend
Metric	AVIR	ALT	PRLD	FENC	VNDA	FHTX	Ind. Median
Rev. Growth	-100.0%	80.0%	138.9%●	65.0%	8.2%	20.1%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on AVIR

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.